{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:10:40Z","timestamp":1790136640983,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1016\/j.eururo.2005.12.019","type":"journal-article","created":{"date-parts":[[2006,1,7]],"date-time":"2006-01-07T12:21:54Z","timestamp":1136636514000},"page":"834-838","source":"Crossref","is-referenced-by-count":42,"title":["Intravesical Instillations with Bacillus Calmette-Gu\u00e9rin for the Treatment of Carcinoma In Situ Involving Prostatic Ducts"],"prefix":"10.1016","volume":"49","author":[{"given":"Juan","family":"Palou Redorta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schatteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Huguet P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9ph","family":"Segarra Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rosales Bordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Villavicencio Mavrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2005.12.019_bib1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","article-title":"Contemporary management of stage T1 transitional cell carcinoma of the bladder","volume":"167","author":"Soloway","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0022-5347(17)42389-5","article-title":"Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Gu\u00e9rin","volume":"139","author":"Hillyard","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00326796","article-title":"Transitional cell carcinoma of the prostate: diagnosis, staging and management","volume":"6","author":"Hardeman","year":"1988","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0090-4295(88)90444-X","article-title":"Importance of early treatment of transitional cell carcinoma of prostatic ducts","volume":"32","author":"Wishnow","year":"1988","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2005.12.019_bib5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Gu\u00e9rin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005392-199501000-00020","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin for treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder","volume":"153","author":"Schellhammer","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-5347(17)58039-8","article-title":"Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis","volume":"118","author":"Schellhammer","year":"1977","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1464-410X.1981.tb03271.x","article-title":"Transitional cell carcinoma involving the prostate","volume":"53","author":"Chibber","year":"1981","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0090-4295(99)80481-6","article-title":"In situ transitional cell carcinoma involvement of the prostatic urethra: bacillus Calmette-Gu\u00e9rin therapy without previous transurethral resection of the prostate","volume":"47","author":"Palou","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2005.12.019_bib10","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-5347(17)41031-7","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for in situ transitional cell carcinoma involving the prostatic urethra","volume":"141","author":"Bretton","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.eururo.2003.12.014","article-title":"Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of bladder","volume":"45","author":"Canda","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0022-5347(17)41585-0","article-title":"Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder","volume":"140","author":"Hardeman","year":"1988","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000019859","article-title":"Significance of bladder biopsies in Ta T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Cancer","volume":"35","author":"Van der Meijden","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-5347(17)36068-8","article-title":"An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients","volume":"149","author":"Sakamoto","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-5347(17)38667-6","article-title":"Identification of transitional cell carcinoma of the prostate in bladder cancer patients: a prospective study","volume":"142","author":"Wood","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib16","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1442-2042.2001.00394.x","article-title":"Clinical study of transitional cell carcinoma of the prostate associated with bladder transitional cell carcinoma","volume":"8","author":"Honda","year":"2001","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Gu\u00e9rin immunotherapy in 1278 patients with bladder cancer","volume":"135","author":"Lamm","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-5347(17)41032-9","article-title":"Editorial comment","volume":"141","author":"Lamm","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-5347(17)37142-2","article-title":"Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy","volume":"147","author":"Reese","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2005.12.019_bib20","series-title":"A commentary on uniform use","article-title":"TNM Supplement","author":"Wittekind","year":"2001"},{"key":"10.1016\/j.eururo.2005.12.019_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eururo.2005.03.021","article-title":"Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor","volume":"48","author":"Huguet","year":"2005","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283805008389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283805008389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T22:07:53Z","timestamp":1555193273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283805008389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S0302283805008389"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2005.12.019","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]}}}